APO Research
Talk to an analyst

APO RESEARCH · REPORT

T Cell Antigen Gp39

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global T Cell Antigen Gp39 Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchT Cell Antigen Gp39 Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal T Cell Antigen Gp39 Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal T Cell Antigen Gp39 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T Cell Antigen Gp39 Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal T Cell Antigen Gp39 Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global T Cell Antigen Gp39 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for T Cell Antigen Gp39 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for T Cell Antigen Gp39 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for T Cell Antigen Gp39 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for T Cell Antigen Gp39 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of T Cell Antigen Gp39 include Biogen, Inc., XL-protein GmbH, Targovax AS, MedImmune, LLC, Juno Therapeutics Inc., ImmuNext, Inc., eTheRNA Immunotherapies NV and Bristol-Myers Squibb Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for T Cell Antigen Gp39, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of T Cell Antigen Gp39, also provides the sales of main regions and countries. Of the upcoming market potential for T Cell Antigen Gp39, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the T Cell Antigen Gp39 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global T Cell Antigen Gp39 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for T Cell Antigen Gp39 sales, projected growth trends, production technology, application and end-user industry.

T Cell Antigen Gp39 Segment by Company

Biogen, Inc.

XL-protein GmbH

Targovax AS

MedImmune, LLC

Juno Therapeutics Inc.

ImmuNext, Inc.

eTheRNA Immunotherapies NV

Bristol-Myers Squibb Company

T Cell Antigen Gp39 Segment by Type

ECI-006

Hepatitis B Vaccine

ISF-35

INX-021

Others

T Cell Antigen Gp39 Segment by Application

Graft Versus Host Disease

Panceratic Cancer

Breast Cancer

Bladder Cancer

Others

T Cell Antigen Gp39 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T Cell Antigen Gp39 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T Cell Antigen Gp39 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T Cell Antigen Gp39.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of T Cell Antigen Gp39 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of T Cell Antigen Gp39 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, T Cell Antigen Gp39 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global T Cell Antigen Gp39 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ECI-006 Major Manufacturers Table 3. Hepatitis B Vaccine Major Manufacturers Table 4. ISF-35 Major Manufacturers Table 5. INX-021 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global T Cell Antigen Gp39 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Graft Versus Host Disease Major Manufacturers Table 9. Panceratic Cancer Major Manufacturers Table 10. Breast Cancer Major Manufacturers Table 11. Bladder Cancer Major Manufacturers Table 12. Others Major Manufacturers Table 13. T Cell Antigen Gp39 Industry Trends Table 14. T Cell Antigen Gp39 Industry Drivers Table 15. T Cell Antigen Gp39 Industry Opportunities and Challenges Table 16. T Cell Antigen Gp39 Industry Restraints Table 17. Global T Cell Antigen Gp39 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global T Cell Antigen Gp39 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global T Cell Antigen Gp39 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global T Cell Antigen Gp39 Revenue Market Share by Region (2021-2026) Table 21. Global T Cell Antigen Gp39 Revenue Market Share by Region (2027-2032) Table 22. Global T Cell Antigen Gp39 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global T Cell Antigen Gp39 Sales by Region (2021-2026) & (K Units) Table 24. Global T Cell Antigen Gp39 Sales by Region (2027-2032) & (K Units) Table 25. Global T Cell Antigen Gp39 Sales Market Share by Region (2021-2026) Table 26. Global T Cell Antigen Gp39 Sales Market Share by Region (2027-2032) Table 27. Global T Cell Antigen Gp39 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global T Cell Antigen Gp39 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global T Cell Antigen Gp39 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global T Cell Antigen Gp39 Sales Market Share by Manufacturers (2021-2026) Table 31. Global T Cell Antigen Gp39 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global T Cell Antigen Gp39 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global T Cell Antigen Gp39 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global T Cell Antigen Gp39 Manufacturers, Product Type & Application Table 35. Global T Cell Antigen Gp39 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global T Cell Antigen Gp39 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global T Cell Antigen Gp39 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global T Cell Antigen Gp39 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global T Cell Antigen Gp39 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global T Cell Antigen Gp39 Revenue Market Share by Type (2021-2026) Table 42. Global T Cell Antigen Gp39 Revenue Market Share by Type (2027-2032) Table 43. Global T Cell Antigen Gp39 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global T Cell Antigen Gp39 Sales by Type (2021-2026) & (K Units) Table 45. Global T Cell Antigen Gp39 Sales by Type (2027-2032) & (K Units) Table 46. Global T Cell Antigen Gp39 Sales Market Share by Type (2021-2026) Table 47. Global T Cell Antigen Gp39 Sales Market Share by Type (2027-2032) Table 48. Global T Cell Antigen Gp39 Price by Type (2021-2026) & (US$/Unit) Table 49. Global T Cell Antigen Gp39 Price by Type (2027-2032) & (US$/Unit) Table 50. Global T Cell Antigen Gp39 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global T Cell Antigen Gp39 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global T Cell Antigen Gp39 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global T Cell Antigen Gp39 Revenue Market Share by Application (2021-2026) Table 54. Global T Cell Antigen Gp39 Revenue Market Share by Application (2027-2032) Table 55. Global T Cell Antigen Gp39 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global T Cell Antigen Gp39 Sales by Application (2021-2026) & (K Units) Table 57. Global T Cell Antigen Gp39 Sales by Application (2027-2032) & (K Units) Table 58. Global T Cell Antigen Gp39 Sales Market Share by Application (2021-2026) Table 59. Global T Cell Antigen Gp39 Sales Market Share by Application (2027-2032) Table 60. Global T Cell Antigen Gp39 Price by Application (2021-2026) & (US$/Unit) Table 61. Global T Cell Antigen Gp39 Price by Application (2027-2032) & (US$/Unit) Table 62. Biogen, Inc. Company Information Table 63. Biogen, Inc. Business Overview Table 64. Biogen, Inc. T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Biogen, Inc. T Cell Antigen Gp39 Product Portfolio Table 66. Biogen, Inc. Recent Development Table 67. XL-protein GmbH Company Information Table 68. XL-protein GmbH Business Overview Table 69. XL-protein GmbH T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. XL-protein GmbH T Cell Antigen Gp39 Product Portfolio Table 71. XL-protein GmbH Recent Development Table 72. Targovax AS Company Information Table 73. Targovax AS Business Overview Table 74. Targovax AS T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Targovax AS T Cell Antigen Gp39 Product Portfolio Table 76. Targovax AS Recent Development Table 77. MedImmune, LLC Company Information Table 78. MedImmune, LLC Business Overview Table 79. MedImmune, LLC T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. MedImmune, LLC T Cell Antigen Gp39 Product Portfolio Table 81. MedImmune, LLC Recent Development Table 82. Juno Therapeutics Inc. Company Information Table 83. Juno Therapeutics Inc. Business Overview Table 84. Juno Therapeutics Inc. T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Juno Therapeutics Inc. T Cell Antigen Gp39 Product Portfolio Table 86. Juno Therapeutics Inc. Recent Development Table 87. ImmuNext, Inc. Company Information Table 88. ImmuNext, Inc. Business Overview Table 89. ImmuNext, Inc. T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. ImmuNext, Inc. T Cell Antigen Gp39 Product Portfolio Table 91. ImmuNext, Inc. Recent Development Table 92. eTheRNA Immunotherapies NV Company Information Table 93. eTheRNA Immunotherapies NV Business Overview Table 94. eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. eTheRNA Immunotherapies NV T Cell Antigen Gp39 Product Portfolio Table 96. eTheRNA Immunotherapies NV Recent Development Table 97. Bristol-Myers Squibb Company Company Information Table 98. Bristol-Myers Squibb Company Business Overview Table 99. Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Bristol-Myers Squibb Company T Cell Antigen Gp39 Product Portfolio Table 101. Bristol-Myers Squibb Company Recent Development Table 102. North America T Cell Antigen Gp39 Revenue by Type (2021-2026) & (US$ Million) Table 103. North America T Cell Antigen Gp39 Revenue by Type (2027-2032) & (US$ Million) Table 104. North America T Cell Antigen Gp39 Sales by Type (2021-2026) & (K Units) Table 105. North America T Cell Antigen Gp39 Sales by Type (2027-2032) & (K Units) Table 106. North America T Cell Antigen Gp39 Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America T Cell Antigen Gp39 Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America T Cell Antigen Gp39 Revenue by Application (2021-2026) & (US$ Million) Table 109. North America T Cell Antigen Gp39 Revenue by Application (2027-2032) & (US$ Million) Table 110. North America T Cell Antigen Gp39 Sales by Application (2021-2026) & (K Units) Table 111. North America T Cell Antigen Gp39 Sales by Application (2027-2032) & (K Units) Table 112. North America T Cell Antigen Gp39 Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America T Cell Antigen Gp39 Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America T Cell Antigen Gp39 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America T Cell Antigen Gp39 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. North America T Cell Antigen Gp39 Sales by Country (2021-2026) & (K Units) Table 119. North America T Cell Antigen Gp39 Sales by Country (2027-2032) & (K Units) Table 120. North America T Cell Antigen Gp39 Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America T Cell Antigen Gp39 Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 123. Canada T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 124. Europe T Cell Antigen Gp39 Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe T Cell Antigen Gp39 Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe T Cell Antigen Gp39 Sales by Type (2021-2026) & (K Units) Table 127. Europe T Cell Antigen Gp39 Sales by Type (2027-2032) & (K Units) Table 128. Europe T Cell Antigen Gp39 Sales Price by Type (2021-2026) & (US$/Unit) Table 129. Europe T Cell Antigen Gp39 Sales Price by Type (2027-2032) & (US$/Unit) Table 130. Europe T Cell Antigen Gp39 Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe T Cell Antigen Gp39 Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe T Cell Antigen Gp39 Sales by Application (2021-2026) & (K Units) Table 133. Europe T Cell Antigen Gp39 Sales by Application (2027-2032) & (K Units) Table 134. Europe T Cell Antigen Gp39 Sales Price by Application (2021-2026) & (US$/Unit) Table 135. Europe T Cell Antigen Gp39 Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Europe T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe T Cell Antigen Gp39 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe T Cell Antigen Gp39 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 140. Europe T Cell Antigen Gp39 Sales by Country (2021-2026) & (K Units) Table 141. Europe T Cell Antigen Gp39 Sales by Country (2027-2032) & (K Units) Table 142. Europe T Cell Antigen Gp39 Sales Price by Country (2021-2026) & (US$/Unit) Table 143. Europe T Cell Antigen Gp39 Sales Price by Country (2027-2032) & (US$/Unit) Table 144. Germany T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 145. France T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 146. U.K. T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 147. Italy T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 148. Netherlands T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 149. China T Cell Antigen Gp39 Revenue by Type (2021-2026) & (US$ Million) Table 150. China T Cell Antigen Gp39 Revenue by Type (2027-2032) & (US$ Million) Table 151. China T Cell Antigen Gp39 Sales by Type (2021-2026) & (K Units) Table 152. China T Cell Antigen Gp39 Sales by Type (2027-2032) & (K Units) Table 153. China T Cell Antigen Gp39 Sales Price by Type (2021-2026) & (US$/Unit) Table 154. China T Cell Antigen Gp39 Sales Price by Type (2027-2032) & (US$/Unit) Table 155. China T Cell Antigen Gp39 Revenue by Application (2021-2026) & (US$ Million) Table 156. China T Cell Antigen Gp39 Revenue by Application (2027-2032) & (US$ Million) Table 157. China T Cell Antigen Gp39 Sales by Application (2021-2026) & (K Units) Table 158. China T Cell Antigen Gp39 Sales by Application (2027-2032) & (K Units) Table 159. China T Cell Antigen Gp39 Sales Price by Application (2021-2026) & (US$/Unit) Table 160. China T Cell Antigen Gp39 Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia T Cell Antigen Gp39 Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia T Cell Antigen Gp39 Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia T Cell Antigen Gp39 Sales by Type (2021-2026) & (K Units) Table 164. Asia T Cell Antigen Gp39 Sales by Type (2027-2032) & (K Units) Table 165. Asia T Cell Antigen Gp39 Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Asia T Cell Antigen Gp39 Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Asia T Cell Antigen Gp39 Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia T Cell Antigen Gp39 Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia T Cell Antigen Gp39 Sales by Application (2021-2026) & (K Units) Table 170. Asia T Cell Antigen Gp39 Sales by Application (2027-2032) & (K Units) Table 171. Asia T Cell Antigen Gp39 Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Asia T Cell Antigen Gp39 Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Asia T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia T Cell Antigen Gp39 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia T Cell Antigen Gp39 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. Asia T Cell Antigen Gp39 Sales by Country (2021-2026) & (K Units) Table 178. Asia T Cell Antigen Gp39 Sales by Country (2027-2032) & (K Units) Table 179. Asia T Cell Antigen Gp39 Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Asia T Cell Antigen Gp39 Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Japan T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 182. South Korea T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 183. India T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 184. Australia T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 185. China Taiwan T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 187. SAMEA T Cell Antigen Gp39 Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA T Cell Antigen Gp39 Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA T Cell Antigen Gp39 Sales by Type (2021-2026) & (K Units) Table 190. SAMEA T Cell Antigen Gp39 Sales by Type (2027-2032) & (K Units) Table 191. SAMEA T Cell Antigen Gp39 Sales Price by Type (2021-2026) & (US$/Unit) Table 192. SAMEA T Cell Antigen Gp39 Sales Price by Type (2027-2032) & (US$/Unit) Table 193. SAMEA T Cell Antigen Gp39 Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA T Cell Antigen Gp39 Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA T Cell Antigen Gp39 Sales by Application (2021-2026) & (K Units) Table 196. SAMEA T Cell Antigen Gp39 Sales by Application (2027-2032) & (K Units) Table 197. SAMEA T Cell Antigen Gp39 Sales Price by Application (2021-2026) & (US$/Unit) Table 198. SAMEA T Cell Antigen Gp39 Sales Price by Application (2027-2032) & (US$/Unit) Table 199. SAMEA T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA T Cell Antigen Gp39 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA T Cell Antigen Gp39 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 203. SAMEA T Cell Antigen Gp39 Sales by Country (2021-2026) & (K Units) Table 204. SAMEA T Cell Antigen Gp39 Sales by Country (2027-2032) & (K Units) Table 205. SAMEA T Cell Antigen Gp39 Sales Price by Country (2021-2026) & (US$/Unit) Table 206. SAMEA T Cell Antigen Gp39 Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Brazil T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 208. Argentina T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 209. Chile T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 210. Colombia T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 211. Peru T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 213. Israel T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 214. UAE T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 215. Turkey T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 216. Iran T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 217. Egypt T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. T Cell Antigen Gp39 Distributors List Table 221. T Cell Antigen Gp39 Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. T Cell Antigen Gp39 Image Figure 2. Global T Cell Antigen Gp39 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global T Cell Antigen Gp39 Market Size Share 2021 VS 2025 VS 2032 Figure 4. ECI-006 Image Figure 5. Hepatitis B Vaccine Image Figure 6. ISF-35 Image Figure 7. INX-021 Image Figure 8. Others Image Figure 9. Global T Cell Antigen Gp39 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global T Cell Antigen Gp39 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Graft Versus Host Disease Image Figure 12. Panceratic Cancer Image Figure 13. Breast Cancer Image Figure 14. Bladder Cancer Image Figure 15. Others Image Figure 16. Global T Cell Antigen Gp39 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global T Cell Antigen Gp39 Revenue (2021-2032) & (US$ Million) Figure 18. Global T Cell Antigen Gp39 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global T Cell Antigen Gp39 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global T Cell Antigen Gp39 Revenue Market Share by Region (2021-2032) Figure 21. Global T Cell Antigen Gp39 Sales (2021-2032) & (K Units) Figure 22. Global T Cell Antigen Gp39 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global T Cell Antigen Gp39 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico T Cell Antigen Gp39 Sales YoY (2021-2032) & (K Units) Figure 25. Europe T Cell Antigen Gp39 Sales YoY (2021-2032) & (K Units) Figure 26. China T Cell Antigen Gp39 Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) T Cell Antigen Gp39 Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa T Cell Antigen Gp39 Sales YoY (2021-2032) & (K Units) Figure 29. Global T Cell Antigen Gp39 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global T Cell Antigen Gp39 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global T Cell Antigen Gp39 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global T Cell Antigen Gp39 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global T Cell Antigen Gp39 Revenue Market Share by Type (2021-2032) Figure 35. Global T Cell Antigen Gp39 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global T Cell Antigen Gp39 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global T Cell Antigen Gp39 Sales Market Share by Type (2021-2032) Figure 38. Global T Cell Antigen Gp39 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global T Cell Antigen Gp39 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global T Cell Antigen Gp39 Revenue Market Share by Application (2021-2032) Figure 41. Global T Cell Antigen Gp39 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global T Cell Antigen Gp39 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global T Cell Antigen Gp39 Sales Market Share by Application (2021-2032) Figure 44. North America T Cell Antigen Gp39 Revenue Share by Type (2021-2032) Figure 45. North America T Cell Antigen Gp39 Sales Share by Type (2021-2032) Figure 46. North America T Cell Antigen Gp39 Revenue Share by Application (2021-2032) Figure 47. North America T Cell Antigen Gp39 Sales Share by Application (2021-2032) Figure 48. North America T Cell Antigen Gp39 Revenue Share by Country (2021-2032) Figure 49. North America T Cell Antigen Gp39 Sales Share by Country (2021-2032) Figure 50. Europe T Cell Antigen Gp39 Revenue Share by Type (2021-2032) Figure 51. Europe T Cell Antigen Gp39 Sales Share by Type (2021-2032) Figure 52. Europe T Cell Antigen Gp39 Revenue Share by Application (2021-2032) Figure 53. Europe T Cell Antigen Gp39 Sales Share by Application (2021-2032) Figure 54. Europe T Cell Antigen Gp39 Revenue Share by Country (2021-2032) Figure 55. Europe T Cell Antigen Gp39 Sales Share by Country (2021-2032) Figure 56. China T Cell Antigen Gp39 Revenue Share by Type (2021-2032) Figure 57. China T Cell Antigen Gp39 Sales Share by Type (2021-2032) Figure 58. China T Cell Antigen Gp39 Revenue Share by Application (2021-2032) Figure 59. China T Cell Antigen Gp39 Sales Share by Application (2021-2032) Figure 60. Asia T Cell Antigen Gp39 Revenue Share by Type (2021-2032) Figure 61. Asia T Cell Antigen Gp39 Sales Share by Type (2021-2032) Figure 62. Asia T Cell Antigen Gp39 Revenue Share by Application (2021-2032) Figure 63. Asia T Cell Antigen Gp39 Sales Share by Application (2021-2032) Figure 64. Asia T Cell Antigen Gp39 Revenue Share by Country (2021-2032) Figure 65. Asia T Cell Antigen Gp39 Sales Share by Country (2021-2032) Figure 66. SAMEA T Cell Antigen Gp39 Revenue Share by Type (2021-2032) Figure 67. SAMEA T Cell Antigen Gp39 Sales Share by Type (2021-2032) Figure 68. SAMEA T Cell Antigen Gp39 Revenue Share by Application (2021-2032) Figure 69. SAMEA T Cell Antigen Gp39 Sales Share by Application (2021-2032) Figure 70. SAMEA T Cell Antigen Gp39 Revenue Share by Country (2021-2032) Figure 71. SAMEA T Cell Antigen Gp39 Sales Share by Country (2021-2032) Figure 72. T Cell Antigen Gp39 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. T Cell Antigen Gp39 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • ECI-006
  • Hepatitis B Vaccine
  • ISF-35
  • INX-021
  • Others
Applications
  • Graft Versus Host Disease
  • Panceratic Cancer
  • Breast Cancer
  • Bladder Cancer
  • Others
Companies covered
  • Biogen, Inc.
  • XL-protein GmbH
  • Targovax AS
  • MedImmune, LLC
  • Juno Therapeutics Inc.
  • ImmuNext, Inc.
  • eTheRNA Immunotherapies NV
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 T Cell Antigen Gp39 Market by Type
  3. 1.2.1 Global T Cell Antigen Gp39 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ECI-006
  5. 1.2.3 Hepatitis B Vaccine
  6. 1.2.4 ISF-35
  7. 1.2.5 INX-021
  8. 1.2.6 Others
  9. 1.3 T Cell Antigen Gp39 Market by Application
  10. 1.3.1 Global T Cell Antigen Gp39 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Graft Versus Host Disease
  12. 1.3.3 Panceratic Cancer
  13. 1.3.4 Breast Cancer
  14. 1.3.5 Bladder Cancer
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 T Cell Antigen Gp39 Market Dynamics
  1. 2.1 T Cell Antigen Gp39 Industry Trends
  2. 2.2 T Cell Antigen Gp39 Industry Drivers
  3. 2.3 T Cell Antigen Gp39 Industry Opportunities and Challenges
  4. 2.4 T Cell Antigen Gp39 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global T Cell Antigen Gp39 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global T Cell Antigen Gp39 Revenue by Region
  3. 3.2.1 Global T Cell Antigen Gp39 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global T Cell Antigen Gp39 Revenue by Region (2021-2026)
  5. 3.2.3 Global T Cell Antigen Gp39 Revenue by Region (2027-2032)
  6. 3.2.4 Global T Cell Antigen Gp39 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global T Cell Antigen Gp39 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global T Cell Antigen Gp39 Sales by Region
  9. 3.4.1 Global T Cell Antigen Gp39 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global T Cell Antigen Gp39 Sales by Region (2021-2026)
  11. 3.4.3 Global T Cell Antigen Gp39 Sales by Region (2027-2032)
  12. 3.4.4 Global T Cell Antigen Gp39 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global T Cell Antigen Gp39 Revenue by Manufacturers
  2. 4.1.1 Global T Cell Antigen Gp39 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global T Cell Antigen Gp39 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global T Cell Antigen Gp39 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global T Cell Antigen Gp39 Sales by Manufacturers
  6. 4.2.1 Global T Cell Antigen Gp39 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global T Cell Antigen Gp39 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global T Cell Antigen Gp39 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global T Cell Antigen Gp39 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global T Cell Antigen Gp39 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global T Cell Antigen Gp39 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global T Cell Antigen Gp39 Manufacturers, Product Type & Application
  13. 4.7 Global T Cell Antigen Gp39 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global T Cell Antigen Gp39 Market CR5 and HHI
  16. 4.8.2 2025 T Cell Antigen Gp39 Tier 1, Tier 2, and Tier 3
5 T Cell Antigen Gp39 Market by Type
  1. 5.1 Global T Cell Antigen Gp39 Revenue by Type
  2. 5.1.1 Global T Cell Antigen Gp39 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global T Cell Antigen Gp39 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global T Cell Antigen Gp39 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global T Cell Antigen Gp39 Sales by Type
  6. 5.2.1 Global T Cell Antigen Gp39 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global T Cell Antigen Gp39 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global T Cell Antigen Gp39 Sales Market Share by Type (2021-2032)
  9. 5.3 Global T Cell Antigen Gp39 Price by Type
6 T Cell Antigen Gp39 Market by Application
  1. 6.1 Global T Cell Antigen Gp39 Revenue by Application
  2. 6.1.1 Global T Cell Antigen Gp39 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global T Cell Antigen Gp39 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global T Cell Antigen Gp39 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global T Cell Antigen Gp39 Sales by Application
  6. 6.2.1 Global T Cell Antigen Gp39 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global T Cell Antigen Gp39 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global T Cell Antigen Gp39 Sales Market Share by Application (2021-2032)
  9. 6.3 Global T Cell Antigen Gp39 Price by Application
7 Company Profiles
  1. 7.1 Biogen, Inc.
  2. 7.1.1 Biogen, Inc. Company Information
  3. 7.1.2 Biogen, Inc. Business Overview
  4. 7.1.3 Biogen, Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Biogen, Inc. T Cell Antigen Gp39 Product Portfolio
  6. 7.1.5 Biogen, Inc. Recent Developments
  7. 7.2 XL-protein GmbH
  8. 7.2.1 XL-protein GmbH Company Information
  9. 7.2.2 XL-protein GmbH Business Overview
  10. 7.2.3 XL-protein GmbH T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 XL-protein GmbH T Cell Antigen Gp39 Product Portfolio
  12. 7.2.5 XL-protein GmbH Recent Developments
  13. 7.3 Targovax AS
  14. 7.3.1 Targovax AS Company Information
  15. 7.3.2 Targovax AS Business Overview
  16. 7.3.3 Targovax AS T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Targovax AS T Cell Antigen Gp39 Product Portfolio
  18. 7.3.5 Targovax AS Recent Developments
  19. 7.4 MedImmune, LLC
  20. 7.4.1 MedImmune, LLC Company Information
  21. 7.4.2 MedImmune, LLC Business Overview
  22. 7.4.3 MedImmune, LLC T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 MedImmune, LLC T Cell Antigen Gp39 Product Portfolio
  24. 7.4.5 MedImmune, LLC Recent Developments
  25. 7.5 Juno Therapeutics Inc.
  26. 7.5.1 Juno Therapeutics Inc. Company Information
  27. 7.5.2 Juno Therapeutics Inc. Business Overview
  28. 7.5.3 Juno Therapeutics Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Juno Therapeutics Inc. T Cell Antigen Gp39 Product Portfolio
  30. 7.5.5 Juno Therapeutics Inc. Recent Developments
  31. 7.6 ImmuNext, Inc.
  32. 7.6.1 ImmuNext, Inc. Company Information
  33. 7.6.2 ImmuNext, Inc. Business Overview
  34. 7.6.3 ImmuNext, Inc. T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 ImmuNext, Inc. T Cell Antigen Gp39 Product Portfolio
  36. 7.6.5 ImmuNext, Inc. Recent Developments
  37. 7.7 eTheRNA Immunotherapies NV
  38. 7.7.1 eTheRNA Immunotherapies NV Company Information
  39. 7.7.2 eTheRNA Immunotherapies NV Business Overview
  40. 7.7.3 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Product Portfolio
  42. 7.7.5 eTheRNA Immunotherapies NV Recent Developments
  43. 7.8 Bristol-Myers Squibb Company
  44. 7.8.1 Bristol-Myers Squibb Company Company Information
  45. 7.8.2 Bristol-Myers Squibb Company Business Overview
  46. 7.8.3 Bristol-Myers Squibb Company T Cell Antigen Gp39 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bristol-Myers Squibb Company T Cell Antigen Gp39 Product Portfolio
  48. 7.8.5 Bristol-Myers Squibb Company Recent Developments
8 North America
  1. 8.1 North America T Cell Antigen Gp39 Market Size by Type
  2. 8.1.1 North America T Cell Antigen Gp39 Revenue by Type (2021-2032)
  3. 8.1.2 North America T Cell Antigen Gp39 Sales by Type (2021-2032)
  4. 8.1.3 North America T Cell Antigen Gp39 Price by Type (2021-2032)
  5. 8.2 North America T Cell Antigen Gp39 Market Size by Application
  6. 8.2.1 North America T Cell Antigen Gp39 Revenue by Application (2021-2032)
  7. 8.2.2 North America T Cell Antigen Gp39 Sales by Application (2021-2032)
  8. 8.2.3 North America T Cell Antigen Gp39 Price by Application (2021-2032)
  9. 8.3 North America T Cell Antigen Gp39 Market Size by Country
  10. 8.3.1 North America T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America T Cell Antigen Gp39 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe T Cell Antigen Gp39 Market Size by Type
  2. 9.1.1 Europe T Cell Antigen Gp39 Revenue by Type (2021-2032)
  3. 9.1.2 Europe T Cell Antigen Gp39 Sales by Type (2021-2032)
  4. 9.1.3 Europe T Cell Antigen Gp39 Price by Type (2021-2032)
  5. 9.2 Europe T Cell Antigen Gp39 Market Size by Application
  6. 9.2.1 Europe T Cell Antigen Gp39 Revenue by Application (2021-2032)
  7. 9.2.2 Europe T Cell Antigen Gp39 Sales by Application (2021-2032)
  8. 9.2.3 Europe T Cell Antigen Gp39 Price by Application (2021-2032)
  9. 9.3 Europe T Cell Antigen Gp39 Market Size by Country
  10. 9.3.1 Europe T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe T Cell Antigen Gp39 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China T Cell Antigen Gp39 Market Size by Type
  2. 10.1.1 China T Cell Antigen Gp39 Revenue by Type (2021-2032)
  3. 10.1.2 China T Cell Antigen Gp39 Sales by Type (2021-2032)
  4. 10.1.3 China T Cell Antigen Gp39 Price by Type (2021-2032)
  5. 10.2 China T Cell Antigen Gp39 Market Size by Application
  6. 10.2.1 China T Cell Antigen Gp39 Revenue by Application (2021-2032)
  7. 10.2.2 China T Cell Antigen Gp39 Sales by Application (2021-2032)
  8. 10.2.3 China T Cell Antigen Gp39 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia T Cell Antigen Gp39 Market Size by Type
  2. 11.1.1 Asia T Cell Antigen Gp39 Revenue by Type (2021-2032)
  3. 11.1.2 Asia T Cell Antigen Gp39 Sales by Type (2021-2032)
  4. 11.1.3 Asia T Cell Antigen Gp39 Price by Type (2021-2032)
  5. 11.2 Asia T Cell Antigen Gp39 Market Size by Application
  6. 11.2.1 Asia T Cell Antigen Gp39 Revenue by Application (2021-2032)
  7. 11.2.2 Asia T Cell Antigen Gp39 Sales by Application (2021-2032)
  8. 11.2.3 Asia T Cell Antigen Gp39 Price by Application (2021-2032)
  9. 11.3 Asia T Cell Antigen Gp39 Market Size by Country
  10. 11.3.1 Asia T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia T Cell Antigen Gp39 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA T Cell Antigen Gp39 Market Size by Type
  2. 12.1.1 SAMEA T Cell Antigen Gp39 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA T Cell Antigen Gp39 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA T Cell Antigen Gp39 Price by Type (2021-2032)
  5. 12.2 SAMEA T Cell Antigen Gp39 Market Size by Application
  6. 12.2.1 SAMEA T Cell Antigen Gp39 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA T Cell Antigen Gp39 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA T Cell Antigen Gp39 Price by Application (2021-2032)
  9. 12.3 SAMEA T Cell Antigen Gp39 Market Size by Country
  10. 12.3.1 SAMEA T Cell Antigen Gp39 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA T Cell Antigen Gp39 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA T Cell Antigen Gp39 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 T Cell Antigen Gp39 Value Chain Analysis
  2. 13.1.1 T Cell Antigen Gp39 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 T Cell Antigen Gp39 Production Mode & Process
  6. 13.2 T Cell Antigen Gp39 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 T Cell Antigen Gp39 Distributors
  9. 13.2.3 T Cell Antigen Gp39 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst